Expression of microRNA-1234 related signal transducer and activator of transcription 3 in patients with diffuse large B-cell lymphoma of activated B-cell like type from high and low infectious disease areas

Leukemia and Lymphoma

Volumn 55, Issue 5, 2014, Pages 1158-1165

  Högfeldt, Therese ^a   Johnsson, Per ^a   Grandér, Dan ^a   Bahnassy, Abeer A ^b   Porwit, Anna ^b   Eid, Salem ^b   Österborg, Anders ^a   Zekri, Abdel Rahman N ^a   Lundahl, Joachim ^a   Khaled, Mustafa Hussein ^c   Mellstedt, Håkan ^a   Moshfegh, Ali ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b TORONTO GENERAL HOSPITAL   (Canada)

^c CAIRO UNIVERSITY   (Egypt)

Author keywords

DLBCL; MiRNA; STAT3

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; MICRORNA; MICRORNA 1234; MITOXANTRONE; PREDNISONE; RITUXIMAB; STAT3 PROTEIN; UNCLASSIFIED DRUG; VINCRISTINE; MIRN-1234 MICRORNA, HUMAN; TRANSCRIPTOME;

ADULT; AGED; ARTICLE; B LYMPHOCYTE ACTIVATION; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CANCER TISSUE; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; EGYPT; EMBRYO; FEMALE; GENE EXPRESSION PROFILING; GENETIC TRANSFECTION; HEK293 CELL LINE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LARGE CELL LYMPHOMA; LYMPH NODE; MALE; MIDDLE AGED; OVERALL SURVIVAL; PRIORITY JOURNAL; SWEDEN; TREATMENT RESPONSE; UPREGULATION; VERY ELDERLY; CASE CONTROL STUDY; CELL LINE; CLUSTER ANALYSIS; GENE EXPRESSION REGULATION; GENETICS; LYMPHOMA, LARGE B-CELL, DIFFUSE; METABOLISM; MORTALITY; RNA INTERFERENCE;

ADULT; AGED; CASE-CONTROL STUDIES; CELL LINE; CLUSTER ANALYSIS; EGYPT; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MICRORNAS; MIDDLE AGED; RNA INTERFERENCE; STAT3 TRANSCRIPTION FACTOR; SWEDEN; TRANSCRIPTOME; TRANSFECTION;

EID: 84899753536     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2013.824077     Document Type: Article

References (43)

1. Aclinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. Blood 1997; 89: 3909-3918.
2. Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identifi ed by gene expression profi ling. Nature 2000; 403: 503-511.
3. Rosenwald A, Wright G, Chan WC, et al. The use of molecular profi ling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 2002; 346: 1937-1947.
4. Jackson RJ, Standart N. How do microRNAs regulate gene expression? Sci STKE 2007; 367:r e1.
5. Valencia-Sanchez M A, Liu J, Hannon G J, et al. Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev 2006; 20: 515-524.
6. Bartel DP. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
7. Lewis B P, Burge C B, Bartel D P. C onserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005; 120: 15-20.
8. Rajewsky N. m icroRNA target predictions in animals. N at Genet 2006; 38(Suppl.): S8-S13.
9. Alvarez-Garcia I, Miska EA. MicroRNA functions in animal development and human disease. Development 2005; 132: 4653-4662.
10. Johnson S M, Grosshans H, Shingara J, et al. RAS is regulated by the let-7 microRNA family. Cell 2005; 120: 635-647.
11. Makunin IV, Pheasant M, Simons C, et al. Orthologous microRNA genes are located in cancer-Associated genomic regions in human and mouse. PLoS One 2007; 2: E1133.
12. Volinia S, Calin GA, Liu CG, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006; 103: 2257-2261.
13. Zhang B, Pan X, Cobb GP, et al. microRNAs as oncogenes and tumor suppressors. Dev Biol 2007; 302: 1-12.
14. Gregory RI, Shiekhattar R. MicroRNA biogenesis and cancer. Cancer Res 2005; 65: 3509-3512.
15. McManus MT. MicroRNAs and cancer. Semin Cancer Biol 2003; 13: 253-258.
16. Lerner M, Harada M, Loven J, et al. DLEU2, frequently deleted in malignancy, functions as a critical host gene of the cell cycle inhibitory microRNAs miR-15a and miR-16-1. Exp Cell Res 2009; 315: 2941-2952.
17. Calin GA, Dumitru CD, Shimizu M, et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002; 99: 15524-15529.
18. Xu W, Li JY. MicroRNA gene expression in malignant lymphoproliferative disorders. Chin Med J (Engl) 2007; 120: 996-999.
19. Darnell JE Jr. STATs and gene regulation. Science 1997; 277: 1630-1635.
20. Darnell JE Jr, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994; 264: 1415-1421.
21. Liu Y, Deng J, Wang L, et a l. S 1PR1 is an effective target to block STAT3 signaling in activated B cell-like diffuse large B-cell lymphoma. Blood 2012; 120: 1458-1465.
22. Lam LT, Wright G, Davis RE, et al. Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor-{kappa}B pathways in subtypes of diffuse large B-cell lymphoma. Blood 2008; 111: 3701-3713.
23. Parkin DM. The global health burden of infection-Associated cancers in the year 2002. Int J Cancer 2006; 118: 3030-3044.
24. Hogfeldt T, Bahnassy AA, Kwiecinska A, et al. Patients with activated B-cell like diffuse large B-cell lymphoma in high and low infectious disease areas have different inflammatory gene signatures. Leuk Lymphoma 2013; 54: 996-1003.
25. Hans C P, Weisenburger D D, Greiner T C, et al. Confi rmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004; 103: 275-282.
26. Meyer PN, Fu K, Greiner TC, et al. Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab. J Clin Oncol 2011; 29: 200-207.
27. Jacobson TA, Lundahl J, Mellstedt H, et al. Gene expression analysis using long-Term preserved formalin-fi xed and paraffi n-embedded tissue of non-small cell lung cancer. Int J Oncol 2011; 38: 1075-1081.
28. Dweep H, Sticht C, Pandey P, et al. miRWalk-database: Prediction of possible miRNA binding sites by ' walking ' the genes of three genomes. J Biomed Inform 2011; 44: 839-847.
29. Johnsson P, Ackley A, Vidarsdottir L, et al. A pseudogene long-noncoding-RNA network regulates PTEN transcription and translation in human cells. Nat Struct Mol Biol 2013; 20: 440-446.
30. Coiffier B. Diffuse large cell lymphoma. Curr Opin Oncol 2001; 13: 325-334.
31. Engels E A, Cho E R, Jee S H. Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: A cohort study. Lancet Oncol 2010; 11: 827-834.
32. Smith AL, Iwanaga R, Drasin DJ, et al. The miR-106b-25 cluster targets Smad7, activates TGF-beta signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer. Oncogene 2012; 31: 5162-5171.
33. Iliopoulos D, Hirsch H A, Struhl K. A n epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. Cell 2009; 139: 693-706.
34. Sayed D, Abdellatif M. MicroRNAs in development and disease. Physiol Rev 2011; 91: 827-887.
35. Ma X, Becker Buscaglia LE, Barker JR, et al. MicroRNAs in NF-kappaB signaling. J Mol Cell Biol 2011; 3: 159-166.
36. Lin Z, Flemington EK. miRNAs in the pathogenesis of oncogenic human viruses. Cancer Lett 2011; 305: 186-199.
37. Liu WH, Yeh SH, Chen PJ. Role of microRNAs in hepatitis B virus replication and pathogenesis. Biochim Biophys Acta 2011; 1809: 678-685.
38. Pfeff er S, Zavolan M, Grasser F A, et al. Identification of virusencoded microRNAs. Science 2004; 304: 734-736.
39. Li P, Harris D, Liu Z, et al. Stat3 activates the receptor tyrosine kinase like orphan receptor-1 gene in chronic lymphocytic leukemia cells. PLoS One 2010; 5: E11859.
40. Loffler D, Brocke-Heidrich K, Pfeifer G, et al. Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer. Blood 2007; 110: 1330-1333.
41. Kohanbash G, Okada H. MicroRNAs and STAT interplay. Semin Cancer Biol 2012; 22: 70-75.
42. Apredictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 1993; 329: 987-994.
43. Tilly H, Dreyling M, Group EGW. Diffuse large B-cell non-Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010; 21(Suppl. 5): V172-v174.